We previously identiˆed a 65-kDa protein (p65) that was phosphorylated in activated macrophages. It has turned out to be a murine homologue of human Lplastin, which was identiˆed as a novel protein in human cancer cells. p65 W L-plastin is characterized by a series of Ca 2＋ -, calmodulin-, and actin-binding domains, and is thought to play a crucial role in leukocytes and cancer cells. We have expressed a recombinant (r) p65 W L-plastin in Escherichia coli that binds to bactin and prepared high-titer antibodies using large amounts of the protein as immunogen. Anti-rp65 W Lplastin antibodies recognize native p65 W L-plastin as well as rp65 W L-plastin and have enabled us to detect theˆne structures of intracellular p65 W L-plastin, and it was found that its localization was extensively changed by stimulation with bacterial components. We further developed an enzyme-linked immunosorbent assay system and a ‰ow cytometry method using these reagents, which made it possible to measure antibodies, including autoantibodies, against p65 W L-plastin and to evaluate the maturation-dependent expression of the protein in leukocytes.
Nonmuscle actin is one of the most essential proteins of all eucaryotic cells, where it is centrally involved in diverse cellular functions such as cell motility, cell division, cellular adhesion, and control of cellular shape.
1) The actin cytoskeleton system is especially important in lymphocytes and macrophages that are highly motile and can rapidly move to infectious and in‰ammatory sites. We previously puriˆed and identiˆed a 65-kDa cytosolic protein (p65) that was heavily phosphorylated in macrophages in response to bacterial lipopolysaccharide (LPS), and demonstrated that the protein contains two N-terminal Ca 2＋ -binding domains, a calmodulin-domain, and two actin-binding domains. [2] [3] [4] Interestingly, it has turned out to be a murine homologue of human L-plastin that was originally identiˆed as a novel transformationinduced protein in human neoplastic cells. 5, 6) Plastins are a family of actin-binding proteins that are evolutionarily conserved and expressed in animal and plant cells. 2, 5, 7) Three plastin isoforms, L-plastin, T-plastin, and I-plastin, have been identiˆed in humans.
5) The T-plastin isoform is constitutively expressed in epithelial and mesenchymal cells, whereas I-plastin expression is restricted to absorptive intestinal and kidney cells. 8) The p65 W L-plastin isoform is expressed in hemopoietic cell lineages and in many types of human epithelial cancer cells. 3, 5, 9, 10) It has been shown that p65 W L-plastin is phosphorylated in various leukocytes including lymphocytes, granulocytes, and macrophages in response to extracellular stimuli, 2, [11] [12] [13] suggesting that p65 W Lplastin exerts its function on the actin cytoskeleton in a phosphorylation-dependent manner. In this respect, we identiˆed the phosphorylation site of p65 W L-plastin (Ser-5) by isolating a phosphopeptide derived from the protein.
4) It has recently been clariˆed that the Ser-5 phosphorylation of p65 W L-plastin regulates b2-integrin-mediated leukocyte adhesion. 14) To investigate the biological functions of p65 W Lplastin in more detail, we prepared a recombinant (r) murine p65 W L-plastin in Escherichia coli and hightiter antibodies against the protein. We also developed experimental procedures using these reagents.
Materials and Methods
Mice. Speciˆc pathogen-free ICR mice (8-15 wk old) were purchased from Clea Japan Inc. (Osaka, Japan). All mice were used in accordance with our institutional guidelines for animal experiments.
Expression and puriˆcation of recombinant protein. Recently we cloned the full-length cDNA of murine p65 W L-plastin with the vector lgt11 and analyzed the nucleotide sequences (accession No. D37837) as previously reported. 4) A cDNA fragment containing the whole coding region was ampliˆed using the PCR method with the cloned DNA in lgt11 as a template and two primers (5?-ATCGATCCAT-ATGGCCAGAGGATCCGTGTCTGACG-3?, including the sequences for N-terminal amino acids and an additional NdeI site, and 5?-CTGAATTCT-GGGACTTACACCCTCTTCATCCC-3?, including the complementary sequences for C-terminal amino acids and an additional EcoRI site). The PCR product was digested with NdeI and EcoRI and inserted into a bacterial expression vector, pET-3a (Novagen, Inc.). The construct was used to transform E. coli BL-21 (DE3) and expression was induced with isopropyl-b-D-thiogalactopyranoside (IPTG). The expression of the target gene was assessed by analysis of E. coli lysates by SDSpolyacrylamide gel electrophoresis (SDS-PAGE) according to the method of Leammli.
15) Large-scale cultures were then done and rp65 W L-plastin was extracted from E. coli by the addition of 100 mg W ml of lysozyme and 0.05z Triton X-100 followed by sonication in the presence of 5 mM EDTA, 5 mM EGTA, 4 mM 2-ME, 1 mM PMSF, and 10 mg W ml leupeptin. The rp65 W L-plastin was recovered in the supernatant of the lysates after centrifugation and further puriˆed by sequential chromatography on Sephacryl S-200 and DEAE-5PW HPLC according to the protocol for purifying native (n) p65 W L-plastin of macrophages as we previously reported.
2)
Peptide microsequence. The puriˆed p65 W L-plastin was digested with lysyl endopepidase. The peptides generated were fractionated by reverse-phase HPLC and underwent microsequence analysis in a 470A gasphase protein sequencer (Applied Biosystem, Inc.) as described.
3)
Antibodies and sera. Two rabbits wereˆrst immunized, each with 1 mg of rp65 W L-plastin in complete Freund's adjuvant (Difco Laboratories). Three weeks later, the rabbits were immunized again with 1 mg of rp65 W L-plastin in incomplete Freund's adjuvant (Difco). Two weeks later, the rabbits were bled and the sera were heat-inactivated and used as the antibody source. Sera from patients who had a positive diagnosis for systemic lupus erythematosus (SLE) and normal volunteers were obtained with informed consent.
Western blot analysis. Western blot analysis was done as we previously described. 2) In brief, puriˆed rp65 or macrophage extracts were solubilized in SDS-PAGE sample buŠer and analyzed on 12z SDS-PAGE gels. Samples separated by SDS-PAGE were electrophoretically transferred to PVDF membranes. The membranes were blocked with 5z skimmed milk in Tris-buŠered saline (TBS), washed, and reacted with rabbit antibodies against np65 W L-plastin of macrophages that we previously prepared 2) or antirp65 W L-plastin antibodies. After washes, the membranes were reacted with horseradish peroxidase (HRP)-coupled protein A and washed. Bands were detected using ECL Western blotting detection reagents (Amersham Pharmacia, Biotech).
Binding assay of rp65 W L-plastin with b-actin. Nonmuscle b-actin of macrophages was puriˆed as previously described.
16) b-actin (0.3 mg W ml) were reacted with rp65 W L-plastin (0.07 mg W ml) in reaction buŠer (0.1 M KCl, 1 mM MgCl2, 1 mM EGTA, 0.1 mM ATP, and 50 mM sodium phosphate, pH 7.0) for 2 hr at 259 C. The reaction mixture was ultracentrifuged for 30 min at 100,000×g and the pellet was analyzed by SDS-PAGE. The reaction mixture was also put onto a carbon-coated grid and negatively stained with 2z uranyl acetate. Protein complexes on the grid were examined in an electron microscope (Hitachi, Inc., Japan).
ELISA assay. An ELISA assay for detecting antip65 W L-plastin antibodies was done as we previously described. 17) In brief, microtiter plates (Nunc, Denmark) were coated with 100 ml of rp65 W L-plastin (0.5 mg W ml) in 0.1 M carbonate-bicarbonate buŠer (pH 8.5) by incubation overnight at 49 C. After plates were blocked with PBS containing 1z bovine serum albumin (BSA) and washed with PBS containing 0.02z Tween 20, 100 ml of serial dilutions of antirp65 W L-plastin or anti-np65 W L-plastin antibodies were added to each well, and plates were incubated for 1 hr at 379 C. After washes, 100 ml of 1 W 2000 diluted HRP-conjugated protein A (Pharmacia) was added, followed by incubation for 0.5 hr at 379 C. After washes, 100 ml of enzyme substrate (0.4 mg W ml of o-phenylenediamine in reaction buŠer) was added to each well, and the plates were incubated for 20 min at 379 C. The reaction was stopped by adding H2SO4, and the absorbance at 492 nm was measured by an ELISA reader (Fujirebio Inc., Japan).
Immunohistochemical analysis. Peritoneal resident cells obtained from mice were allowed to adhere on cover slips for 2 hr in RPMI 1640 medium supplemented with 2 mM L-glutamine, 100 U W ml penicillin, 100 mg W ml streptomycin, 50 mM 2-ME, and 2z heat-inactivated FCS. After non-adherent cells were washed oŠ, adherent macrophages were stimulated with bacterial lipopolysccharide (Sigma; 100 ng W ml) or bacterial organisms such as E. coli and S. aureus for 2 hr. Immunostaining was done by the protocol as previously described with a slight modiˆcation. Brie‰y, macrophages wereˆxed with 0.1 M PBS containing 2z paraformaldehyde and 4z sucrose at room temperature (RT). Theˆxed cells were treated with 50 mM NH4Cl, permeabilized with PBS containing 0.1z saponin for 10 min at RT, washed, and blocked with PBS containing 2z FCS, 2z BSA, and 0.2z gelatin. The cells were then reacted with antirp65 W L-plastin or anti-np65 W L-plastin antibodies, washed, and reacted with Alexa 488-labeled goatanti-rabbit IgG (Molecular Probes). Immuno‰uores-cent signals were detected and photographed with a ‰uorescent microscope (Carl Zeiss, Inc., Germany).
Flow cytometric analysis. Mouse thymocytes and spleen cells wereˆxed and permeabilized as described above with a slight modiˆcation.
19) The cells were reacted with anti-rp65 W L-plastin antibodies, washed, and reacted with ‰uorescein-labeled goat anti-rabbit IgG. Stained cells were analyzed on a FACSCalibur (Becton Dickinson) with the CellQuest software (BD Bioscience).
Results

Expression of recombinant murine p65
The recombinant full-length murine p65 W L-plastin without any tags was expressed in E. coli. rp65 W Lplastin was recovered in a soluble fraction of E. coli lysates. According to the protocol of purifying np65 W L-plastin of macrophages as we already established, 2) rp65 W L-plastin was puriˆed to homogeneity by chromatography on Sephacryl S-200 and HPLC anion exchange (Fig. 1) . About 15 mg of rp65 W L-plastin was puriˆed from a 1-L culture of E. coli; this is equivalent to the content of np65 W L-plastin of peritoneal macrophages from about 10,000 mice.
2)
The puriˆed rp65 W L-plastin was digested with lysyl endopeptidase, and the cleaved peptides were separated by reverse-phase HPLC (data not shown). 
Functional characterization of rp65 W L-plastin
Since p65 W L-plastin has two putative b-actin binding domains, 4) andˆmbrin of Dictyostelium, a chicken homologue of p65 W L-plastin, was shown to bind to b-actin, 20) we assessed the binding capacity of rp65
W L-plastin with b-actin. It was found by ultracentrifugation experiments that rp65 W L-plastin was co-precipitated with polymerized b-actin, indicating that they bind to each other ( Fig. 2A) . Electron microscopical observation further revealed that large protein complexes were formed in the mixture of bactin together with rp65 W L-plastin, whereas only small particles that are supposed to be composed of b-actin were observed in the solution containing bactin alone (Fig. 2B) .
Preparation of high-titer antibodies against p65 W Lplastin
We previously prepared polyclonal antibodies against anti-p65 W L-plastin of macrophages. Their titer, however, was not large because the amount of available antigen in a pure form was extremely limited. Thus, we prepared antibodies from rabbits that had each been immunized with a total of 2 mg of rp65 W L-plastin. As shown in Fig. 3 , the binding capacities of anti-rp65 W L-plastin antibodies are much stronger than those of anti-np65 W L-plastin antibodies in an ELISA system using rp65 W L-plastin as the coating antigen. Likewise, anti-rp65 W L-plastin antibodies reacted with rp65 W L-plastin or np65 W L-plastin in macrophage lysates much more strongly than antinp65 W L-plastin antibodies when detected by Western blot analysis (Fig. 4A and B) . The development of this assay method prompted us to measure autoantibodies against p65 W L-plastin that may be generated in sera of patients with autoimmune diseases like sys- ELISA plates were coated with 100 ml of rp65 W L-plastin (0.5 mg W ml) and 100 ml of serial dilutions of anti-rp65 W L-plastin (, ; rabbit 1, 2), anti-np65 W L-plastin antibodies ($), or normal rabbit serum (NRS) () were tested for binding, which were then reacted with HRP-conjugated protein A, followed by the addition of substrate. temic lupus erythematosus (SLE). Interestingly, one of 3 SLE patients was positive for anti-p65 W L-plastin antibodies (Fig. 4C) , while none of 25 normals were positive (data not shown).
Immunohistochemical analysis using anti-rp65 W Lplastin antibodies
High-titer antibodies against rp65 W L-plastin enabled us to perform immunohistochemical analysis of macrophages. Intracellular np65 W L-plastin in LPSstimulated macrophages was clearly detected by immunostaining with anti-rp65 W L-plastin antibodies, but it was only weakly detected with anti-np65 W Lplastin antibodies (Fig. 5A) . It is intriguing toˆnd that the localization of np65 W L-plastin in macrophages was extensively changed by stimulation with bacterial LPS (Fig. 5A-c) or bacterial organisms such as E. coli and S. aureus (Fig. 5B-b and c) as compared to that in unstimulated resting macrophages (Fig. 5B-a) .
Flow cytometric analysis of intracellular p65 W Lplastin in spleen cells
As we previously reported, p65 W L-plastin is expressed in leukocytes in a maturation-dependent manner.
3) In order to quantitatively assess the content of p65 W L-plastin in individual cells at diŠerent maturation stages, it is essential to establish a ‰ow 1, 2, 3) , and bands were detected as above.
cytometric method detecting intracellular p65 W Lplastin. We thus developed such a procedure involving staining of intracellular p65 W L-plastin by permeabilizing paraformaldehyde-ˆxed spleen cells with saponin as shown in Fig. 6 . Interestingly, the amount of np65 W L-plastin in thymocytes was much lower than that in more mature splenic lymphocytes.
Discussion
In this report, we describe the preparation and characterization of a recombinant murine p65 W Lplastin in E. coli. The recombinant protein can bind to b-actin and be recognized by the antibodies raised against np65 W L-plastin of macrophages. By immunizing rabbits with large amounts of rp65 W L-plastin, we obtained high-titer anti-p65 W L-plastin antibodies that recognize equally well np65 W L-plastin and rp65 W L-plastin and show no cross-reactions to other proteins in macrophages and lymphocytes. The antibodies have made it possible to detect intracellullar np65 W L-plastin. We further developed ELISA and ‰ow cytometric methods using these reagents.
p65 W L-plastin has attracted attention because of its unique characteristics. First, it is expressed exclusively in leukocytes under physiological conditions and phosphorylated when stimulated with various extracellular ligands. The cells belonging to the immune system have to function quickly in response to foreign antigens like microorganisms, which seems to require special molecular and cellular mechanisms. The phosphorylation of p65 W L-plastin may be an essential event for triggering such mechanisms. We previously identiˆed the phosphorylation site of np65 W L-plastin (Ser-5). 4) In connection with this, Jones, S. L. et al. have shown that the Ser-5 phosphorylation of the protein regulates b 2 -integrinmediated leukocyte adhesion, 14) indicating that the protein contributes to celluler adhesion and adhesion-based migration via the modulation of the cytoskeleton system. Though interactions of p65 W Lplastin with the cytoskeleton are largely unknown, we have shown the direct binding of rp65 W L-plastin to b-actin (Fig. 2) . We also demonstrated that the localization of p65 W L-plastin in macrophages were greatly changed by bacterial stimulation (Fig. 5) , which seems to be accompanied by cytoskeletal rearrangement. This may play a key role in initiating the host defenses against bacterial infections. In addition to b-actin, Lollike, K. et al. have recently reported that a penta-EF-hand Ca 2＋ -binding protein, grancalcin, is a binding partner of p65 W L-plastin. 21) We have prepared a recombinant grancalcin protein and are investigating the p65 W L-plastin-involved cellular events in more detail.
Second, p65 W L-plastin is present in the majority of epithelial neoplastic cells though it is not found in normal epithelial cells. The function of p65 W L-plastin in cancer cells is not known but is believed to be similar to that in leukocytes, that is, reorganization of (A) Adherent macrophages that had been stimulated with LPS wereˆxed, permeabilized in 0.1z saponin, and blocked as described in Materials and Methods. Then, samples were reacted with 1 W 100 diluted NRS (a, d), anti-np65 W L-plastin antibodies (b, e), or anti-rp65 W L-plastin antibodies (c, f ). After washes, samples were reacted with Alexa 488-labeled goat-anti-rabbit IgG and observed with a ‰uores-cence microscope, p65 W L-plastin staining (a, b, c), and phase contrast microscopy (d, e, f ). (B) Adherent macrophages that had been unstimulated (a) or stimulated with E. coli (b) and S. aureus (c) were treated as above and observed with a ‰uorescence microscope.
actinˆlaments. Cancer cells may gain the ability to migrate to body tissues like macrophages by expressing the protein. We think that immunohistochemical and ‰ow cytometry methods with anti-rp65 W L-plastin antibodies is highly useful for characterizing cancer cells, and such studies are currently in progress in our laboratory.
Third, p65 W L-plastin has been identiˆed as a selfantigen associated with autoimmune diseases including Vogt-Koyanagi-Harada's syndrome in humans and SLE in an animal model. 22, 23) Molecular mechanisms of how autoreactive T cells from patients and mice with these diseases respond to p65 W L-plastinderived peptides are yet to be clariˆed. Besides autoreactive T cells described in these reports, we have for theˆrst time shown that some patients with autoimmune diseases have autoantibodies against p65 W L-plastin (Fig. 4) .
In summary, the recombinant protein, high-titer speciˆc antibodies, and experimental procedures such as ELISA, immunohistochemical, and ‰ow cytometric methods described in this report, should provide powerful tools in investigating the functions of p65 W L-plastin at the molecular level.
